Literature DB >> 22544677

Immunohistochemical detection of intra-neuronal VZV proteins in snap-frozen human ganglia is confounded by antibodies directed against blood group A1-associated antigens.

Werner J D Ouwendijk1, Sarah E Flowerdew, Desiree Wick, Anja K E Horn, Inga Sinicina, Michael Strupp, Albert D M E Osterhaus, Georges M G M Verjans, Katharina Hüfner.   

Abstract

Varicella-zoster virus (VZV) causes chickenpox, establishes latency in trigeminal (TG) and dorsal root ganglia (DRG), and can lead to herpes zoster upon reactivation. The VZV proteome expressed during latency remains ill-defined, and previous studies have shown discordant data on the spectrum and expression pattern of VZV proteins and transcripts in latently infected human ganglia. Recently, Zerboni and colleagues have provided new insight into this discrepancy (Zerboni et al. in J Virol 86:578-583, 2012). They showed that VZV-specific ascites-derived monoclonal antibody (mAb) preparations contain endogenous antibodies directed against blood group A1 proteins, resulting in false-positive intra-neuronal VZV staining in formalin-fixed human DRG. The aim of the present study was to confirm and extend this phenomenon to snap-frozen TG (n=30) and DRG (n=9) specimens of blood group genotyped donors (n=30). The number of immunohistochemically stained neurons was higher with mAb directed to immediate early protein 62 (IE62) compared with IE63. The IE63 mAb-positive neurons always co-stained for IE62 but not vice versa. The mAb staining was confined to distinct large intra-neuronal vacuoles and restricted to A1(POS) donors. Anti-VZV mAb staining in neurons, but not in VZV-infected cell monolayers, was obliterated after mAb adsorption against blood group A1 erythrocytes. The data presented demonstrate that neuronal VZV protein expression detected by ascites-derived mAb in snap-frozen TG and DRG of blood group A1(POS) donors can be misinterpreted due to the presence of endogenous antibodies directed against blood group A1-associated antigens present in ascites-derived VZV-specific mAb preparations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22544677     DOI: 10.1007/s13365-012-0095-0

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  34 in total

1.  Varicella-Zoster virus gene expression in latently infected rat dorsal root ganglia.

Authors:  P G Kennedy; E Grinfeld; S Bontems; C Sadzot-Delvaux
Journal:  Virology       Date:  2001-10-25       Impact factor: 3.616

2.  Varicella-zoster virus gene expression in latently infected and explanted human ganglia.

Authors:  P G Kennedy; E Grinfeld; J E Bell
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Apparent expression of varicella-zoster virus proteins in latency resulting from reactivity of murine and rabbit antibodies with human blood group a determinants in sensory neurons.

Authors:  Leigh Zerboni; Raymond A Sobel; Michelle Lai; Richard Triglia; Megan Steain; Allison Abendroth; Ann Arvin
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

4.  Laser-capture microdissection: refining estimates of the quantity and distribution of latent herpes simplex virus 1 and varicella-zoster virus DNA in human trigeminal Ganglia at the single-cell level.

Authors:  Kening Wang; Tsz Y Lau; Melissa Morales; Erik K Mont; Stephen E Straus
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

5.  Hemagglutination by mixtures of enterobacterial antigen and Shigella sonnei antiserum.

Authors:  E A Gorzynski; H Brodhage; E Neter
Journal:  Z Hyg Infektionskr       Date:  1964

6.  Prevalence and abundance of latently transcribed varicella-zoster virus genes in human ganglia.

Authors:  Randall J Cohrs; Donald H Gilden
Journal:  J Virol       Date:  2006-12-27       Impact factor: 5.103

7.  Varicella-zoster virus (VZV) transcription during latency in human ganglia: detection of transcripts mapping to genes 21, 29, 62, and 63 in a cDNA library enriched for VZV RNA.

Authors:  R J Cohrs; M Barbour; D H Gilden
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

8.  Detection of varicella-zoster virus DNA in 414 human trigeminal ganglia from cadavers by the polymerase chain reaction: a comparison of the detection rate of varicella-zoster virus and herpes simplex virus type 1.

Authors:  Hiroyuki Inoue; Hisako Motani-Saitoh; Koichi Sakurada; Hiroshi Ikegaya; Daisuke Yajima; Mutsumi Hayakawa; Yayoi Sato; Katsura Otsuka; Kazuhiro Kobayashi; Sayaka Nagasawa; Hirotaro Iwase
Journal:  J Med Virol       Date:  2010-02       Impact factor: 2.327

9.  Translation of varicella-zoster virus genes during human ganglionic latency.

Authors:  Esther Grinfeld; Peter G E Kennedy
Journal:  Virus Genes       Date:  2004-12       Impact factor: 2.332

Review 10.  Varicella-zoster virus.

Authors:  A M Arvin
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

View more
  17 in total

Review 1.  Pathogenesis of varicelloviruses in primates.

Authors:  Werner J D Ouwendijk; Georges M G M Verjans
Journal:  J Pathol       Date:  2015-01       Impact factor: 7.996

Review 2.  A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation.

Authors:  Peter G E Kennedy; Joel Rovnak; Hussain Badani; Randall J Cohrs
Journal:  J Gen Virol       Date:  2015-03-20       Impact factor: 3.891

3.  Neuronal changes induced by Varicella Zoster Virus in a rat model of postherpetic neuralgia.

Authors:  Jean-Marc G Guedon; Michael B Yee; Mingdi Zhang; Stephen A K Harvey; William F Goins; Paul R Kinchington
Journal:  Virology       Date:  2015-04-11       Impact factor: 3.616

Review 4.  Pathogenesis and current approaches to control of varicella-zoster virus infections.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

5.  Comprehensive analysis of varicella-zoster virus proteins using a new monoclonal antibody collection.

Authors:  Tihana Lenac Roviš; Susanne M Bailer; Venkata R Pothineni; Werner J D Ouwendijk; Hrvoje Šimić; Marina Babić; Karmela Miklić; Suzana Malić; Marieke C Verweij; Armin Baiker; Orland Gonzalez; Albrecht von Brunn; Ralf Zimmer; Klaus Früh; Georges M G M Verjans; Stipan Jonjić; Jürgen Haas
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

6.  Presence of a neo-epitope and absence of amyloid beta and tau protein in degenerative hippocampal granules of aged mice.

Authors:  Gemma Manich; Jaume del Valle; Itsaso Cabezón; Antoni Camins; Mercè Pallàs; Carme Pelegrí; Jordi Vilaplana
Journal:  Age (Dordr)       Date:  2013-07-19

Review 7.  T-cell immunity to human alphaherpesviruses.

Authors:  Werner J D Ouwendijk; Kerry J Laing; Georges M G M Verjans; David M Koelle
Journal:  Curr Opin Virol       Date:  2013-05-08       Impact factor: 7.090

8.  T-Cell tropism of simian varicella virus during primary infection.

Authors:  Werner J D Ouwendijk; Ravi Mahalingam; Rik L de Swart; Bart L Haagmans; Geert van Amerongen; Sarah Getu; Don Gilden; Albert D M E Osterhaus; Georges M G M Verjans
Journal:  PLoS Pathog       Date:  2013-05-09       Impact factor: 6.823

9.  In vitro system using human neurons demonstrates that varicella-zoster vaccine virus is impaired for reactivation, but not latency.

Authors:  Tomohiko Sadaoka; Daniel P Depledge; Labchan Rajbhandari; Arun Venkatesan; Judith Breuer; Jeffrey I Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-12       Impact factor: 12.779

10.  Patterns of BAP1 protein expression provide insights into prognostic significance and the biology of uveal melanoma.

Authors:  Neil Farquhar; Sophie Thornton; Sarah E Coupland; Judy M Coulson; Joseph J Sacco; Yamini Krishna; Heinrich Heimann; Azzam Taktak; Colleen M Cebulla; Mohamed H Abdel-Rahman; Helen Kalirai
Journal:  J Pathol Clin Res       Date:  2017-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.